Stockreport

Halozyme Therapeutics: Key Acquisitions To Help Drive Long-Term Growth [Seeking Alpha]

Halozyme Therapeutics, Inc.  (HALO) 
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: halozyme.com/investors/default.aspx
PDF HALO's acquisitions of Elektrofi and Surf Bio extend its IP runway beyond the 2027 ENHANZE patent expiration, supporting long-term revenue sustainability. 2025 revenu [Read more]